ArticleInternational journal of MS care2014

A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.

Andrew D Goodman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.